作者: H. Fürstenwerth
DOI: 10.1111/J.1742-1241.2010.02395.X
关键词: Heart failure 、 Pharmacology 、 Angiotensin receptor 、 Angiotensin-converting enzyme 、 Inotrope 、 Aldosterone Receptor Antagonist 、 Endocrinology 、 Heart disease 、 Insulin 、 Medicine 、 Internal medicine 、 Angiotensin II receptor type 1
摘要: Today, medical therapies for heart disease are based on a diverse range of drugs. Angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, β-adrenergic aldosterone as well diuretics, and inotropic agents improve clinical symptoms slow the progression contractile dysfunction. Despite these therapeutic advances, failure is still associated with an annual mortality rate 10% (1). The search better treatments optimisation existing ones remain major challenges in cardiology.